Avadel Pharmaceuticals plc
AVDL
Market Cap$881.29M
Close$
$-0.47
105% downside
Current Fair Value
105% downsideOvervalued by 105% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $881.29 Million |
|---|---|
| Enterprise Value | $836.93 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.51 |
| Beta | 1.4 |
| Outstanding Shares | 96,601,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -33.32 |
|---|---|
| PEG | 40.63 |
| Price to Sales | 4.72 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.3 |
| Enterprise Value to EBIT | -45.66 |
| Enterprise Value to Net Income | -32 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Avadel Pharmaceuticals plc
CEO: Gregory Divis